H.R. 2355 · 117th Congress · House

Opioid Prescription Verification Act of 2021

In Congress· Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Apr 5, 21
Passed House
Dec 8, 21
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Opioid Prescription Verification Act of 2021

This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).

Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.

In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that

  • maintain a prescription drug monitoring program that mandates the collection of specified information,
  • require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
  • require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.

Previous Versions

07Nov 30, 2021

Opioid Prescription Verification Act of 2021

This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).

Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.

In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that

  • maintain a prescription drug monitoring program that mandates the collection of specified information,
  • require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
  • require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.
00Apr 5, 2021

Opioid Prescription Verification Act of 2021

This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).

Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of individuals who pick up prescribed medications.

In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that

  • maintain a prescription drug monitoring program that mandates the collection of specified information, and
  • require dispensers of certain potentially addictive drugs to verify the identity of individuals who pick up prescribed medications.

Action Timeline

19
  1. DEC 09, 2021IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. DEC 08, 2021Floor

    Passed/agreed to in House

    Roll Call #422

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422).(consideration: CR H7540-7541)

    410Yea
    15Nay
    0NV
  3. DEC 08, 2021Floor

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)

    Roll Call #422
    410Yea
    15Nay
    0NV
  4. DEC 08, 2021Floor

    Motion to reconsider laid on the table Agreed to without objection.

  5. NOV 30, 2021Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.

    117Yea
    180Nay
    0NV
  6. NOV 30, 2021Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.

    117Yea
    180Nay
    0NV
  7. NOV 30, 2021Calendars

    Placed on the Union Calendar, Calendar No. 130.

  8. NOV 30, 2021Floor

    Mr

    Pallone moved to suspend the rules and pass the bill, as amended.

  9. NOV 30, 2021Floor

    Considered under suspension of the rules. (consideration

    CR H6691-6693; text: CR H6691)

    6691Yea
    6693Nay
    0NV
  10. NOV 30, 2021Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.

  11. NOV 30, 2021Floor

    At the conclusion of debate, the Yeas and Nays were demanded and ordered

    Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  12. JUL 21, 2021Committee

    Committee Consideration and Mark-up Session Held.

  13. JUL 21, 2021Committee

    Ordered to be Reported (Amended) by Voice Vote.

  14. JUL 15, 2021Committee

    Subcommittee Consideration and Mark-up Session Held.

  15. JUL 15, 2021Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

  16. APR 13, 2021Committee

    Referred to the Subcommittee on Health.

  17. APR 05, 2021IntroReferral

    Introduced in House

  18. APR 05, 2021IntroReferral

    Introduced in House

  19. APR 05, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

7

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Dec 9, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Nov 30, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jul 21, 2021

Active

Health Subcommittee

hsif14

Referred: Jul 15, 2021

Active

Health Subcommittee

hsif14

Referred: Jul 15, 2021

Active

Health Subcommittee

hsif14

Referred: Apr 13, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Apr 5, 2021

Active